Singapore-based medical device company Genesis MedTech has raised “hundreds of millions” of renminbi in a recent financing round co-led by Wuxi Capital Group and Wuxi Binhu Industrial Investment and Development, alongside a prominent U.S. medical device firm. The funding will support product research and development at its Wuxi facility, as well as expand manufacturing and commercial operations both in China and internationally.
Genesis MedTech specializes in minimally invasive surgery, vascular interventions, and structural heart disease. The company’s portfolio includes an electric endoscopic stapler, antibacterial sutures, an intracranial thrombectomy stent, and an interventional aortic valve, all of which received initial approval in China.- Flcube.com
